Literature DB >> 7098772

Thermogenic and anorectic effects of ephedrine and congeners in mice and rats.

J R Arch, A T Ainsworth, M A Cawthorne.   

Abstract

(-)-Ephedrine has been shown to increase energy expenditure and cause the loss of body fat in rats and mice. The present study compares the effects of (-)- and (+)-ephedrine, (-)- and (+)- pseudoephedrine, (+)- and (+)-norephedrine and (-)- and (+)-norpseudoephedrine on food intake, energy expenditure and body composition in ob/ob and normal mice and food intake in rats. The most potent anorectic and thermogenic compounds had the S configuration at the C-2 position but the orders of potencies for the compounds for anorexia and thermogenesis were not identical. The potencies of the compounds in reducing body lipid content correlated better with their thermogenic than their anorectic potencies.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7098772     DOI: 10.1016/0024-3205(82)90319-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Effects of chronic phenylpropanolamine infusion and termination on body weight, food consumption and water consumption in rats.

Authors:  S E Winders; J C Amos; M R Wilson; P A Rushing; T Dykstra; M C Coday
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

Review 3.  The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology: perspectives from beta3-adrenoceptor agonists.

Authors:  Jonathan R S Arch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-09       Impact factor: 3.000

4.  Detection of thermogenesis in rodents in response to anti-obesity drugs and genetic modification.

Authors:  Jonathan R S Arch; Paul Trayhurn
Journal:  Front Physiol       Date:  2013-04-08       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.